Oncology Molecular Diagnostics Market
According to Intent Market Research, the Oncology Molecular Diagnostics Market is expected to grow from USD 5.2 billion in 2024-e at a CAGR of 13.8% to touch USD 11.2 billion by 2030. The Oncology Molecular Diagnostics Market is dominated by key players such as Roche Diagnostics, Thermo Fisher Scientific, Abbott Laboratories, Qiagen N.V., Agilent Technologies, Illumina, Inc., Bio-Rad Laboratories, Inc., Siemens Healthineers, GE Healthcare, Cepheid, Inc., Hologic, Inc., Foundation Medicine, Inc., Sysmex Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Inc.